Biolase, Inc. short interest in 2019
In 2019, Biolase, Inc.'s disclosed short interest ran from 1.99% of shares outstanding on 15 Jan 2019 to 1.52% on 31 Dec 2019, a change of -0.47 percentage points. The year's high was 7.13% on 31 Oct 2019 and its low 1.35% on 15 Nov 2019, averaging 2.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 67.24 days on 30 Apr 2019. Full history: Biolase, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 1.99% (15 Jan 2019)
- End of year
- 1.52% (31 Dec 2019)
- Change
- -0.47 pp
- High
- 7.13% (31 Oct 2019)
- Low
- 1.35% (15 Nov 2019)
- Average
- 2.31%
- Highest days to cover
- 67.24 (30 Apr 2019)
- SEC filings marked
- 9
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 1.99% | 33.71 | |
| 31 Jan 2019 | 2.06% | 8.77 | |
| 15 Feb 2019 | 2.05% | 4.76 | |
| 28 Feb 2019 | 1.92% | 4.24 | |
| 15 Mar 2019 | 2.11% | 7.13 | results (8-K), 10-K filed |
| 29 Mar 2019 | 2.10% | 16.22 | |
| 15 Apr 2019 | 2.05% | 22.98 | |
| 30 Apr 2019 | 2.06% | 67.24 | |
| 15 May 2019 | 2.02% | 29.04 | results (8-K), 10-Q filed |
| 31 May 2019 | 1.91% | 22.12 | |
| 14 Jun 2019 | 1.92% | 19.93 | |
| 28 Jun 2019 | 2.00% | 3.53 | |
| 15 Jul 2019 | 2.16% | 8.15 | |
| 31 Jul 2019 | 2.17% | 30.92 | |
| 15 Aug 2019 | 2.14% | 26.74 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 2.40% | 16.75 | |
| 13 Sep 2019 | 2.68% | 11.46 | |
| 30 Sep 2019 | 3.19% | 12.97 | |
| 15 Oct 2019 | 3.45% | 7.16 | |
| 31 Oct 2019 | 7.13% | 5.05 | results (8-K) |
| 15 Nov 2019 | 1.35% | 3.37 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 1.58% | 5.35 | |
| 13 Dec 2019 | 1.55% | 2.81 | |
| 31 Dec 2019 | 1.52% | 3.79 |
See also: Biolase, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.